JP2022549140A5 - - Google Patents

Info

Publication number
JP2022549140A5
JP2022549140A5 JP2022517343A JP2022517343A JP2022549140A5 JP 2022549140 A5 JP2022549140 A5 JP 2022549140A5 JP 2022517343 A JP2022517343 A JP 2022517343A JP 2022517343 A JP2022517343 A JP 2022517343A JP 2022549140 A5 JP2022549140 A5 JP 2022549140A5
Authority
JP
Japan
Prior art keywords
pkp2
gene therapy
therapy vector
therapeutic formulation
isoform
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022517343A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022549140A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/076290 external-priority patent/WO2021053222A1/en
Publication of JP2022549140A publication Critical patent/JP2022549140A/ja
Publication of JP2022549140A5 publication Critical patent/JP2022549140A5/ja
Priority to JP2026021870A priority Critical patent/JP2026116276A/ja
Pending legal-status Critical Current

Links

JP2022517343A 2019-09-20 2020-09-21 遺伝子療法組成物および不整脈源性右心室心筋症の治療 Pending JP2022549140A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026021870A JP2026116276A (ja) 2019-09-20 2026-02-13 遺伝子療法組成物および不整脈源性右心室心筋症の治療

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962903103P 2019-09-20 2019-09-20
US62/903,103 2019-09-20
PCT/EP2020/076290 WO2021053222A1 (en) 2019-09-20 2020-09-21 Gene therapy composition and treatment of right ventricular arrythmogenic cardiomyopathy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026021870A Division JP2026116276A (ja) 2019-09-20 2026-02-13 遺伝子療法組成物および不整脈源性右心室心筋症の治療

Publications (2)

Publication Number Publication Date
JP2022549140A JP2022549140A (ja) 2022-11-24
JP2022549140A5 true JP2022549140A5 (cg-RX-API-DMAC7.html) 2023-09-22

Family

ID=72615856

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022517343A Pending JP2022549140A (ja) 2019-09-20 2020-09-21 遺伝子療法組成物および不整脈源性右心室心筋症の治療
JP2026021870A Pending JP2026116276A (ja) 2019-09-20 2026-02-13 遺伝子療法組成物および不整脈源性右心室心筋症の治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026021870A Pending JP2026116276A (ja) 2019-09-20 2026-02-13 遺伝子療法組成物および不整脈源性右心室心筋症の治療

Country Status (9)

Country Link
US (3) US20220389452A1 (cg-RX-API-DMAC7.html)
EP (1) EP4031672A1 (cg-RX-API-DMAC7.html)
JP (2) JP2022549140A (cg-RX-API-DMAC7.html)
KR (1) KR20220066914A (cg-RX-API-DMAC7.html)
AU (1) AU2020350140A1 (cg-RX-API-DMAC7.html)
CA (1) CA3151036A1 (cg-RX-API-DMAC7.html)
IL (1) IL291488A (cg-RX-API-DMAC7.html)
TW (1) TWI897882B (cg-RX-API-DMAC7.html)
WO (1) WO2021053222A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114450411A (zh) 2019-04-01 2022-05-06 特纳亚治疗股份有限公司 具有工程化衣壳的腺相关病毒
WO2021142267A1 (en) * 2020-01-08 2021-07-15 Scarpmap Llc Methods and computing system for processing ultrasound image to determine health of subdermal tissue
FI4103214T3 (fi) 2020-02-13 2026-07-03 Tenaya Therapeutics Inc Geeniterapian vektorit sydänsairauden hoitoon
WO2022032226A1 (en) * 2020-08-07 2022-02-10 Spacecraft Seven, Llc Plakophilin-2 (pkp2) gene therapy using aav vector
JP7415042B2 (ja) 2020-10-09 2024-01-16 テナヤ セラピューティクス, インコーポレイテッド プラコフィリン2遺伝子治療の方法および組成物
US11781156B2 (en) * 2020-10-09 2023-10-10 Tenaya Therapeutics, Inc. Plakophillin-2 gene therapy methods and compositions
CA3212043A1 (en) * 2021-03-19 2022-09-22 Ucl Business Plc Gene therapy composition and treatment of right ventricular arrhythmogenic cardiomyopathy
BR112023021037A2 (pt) * 2021-04-12 2023-12-19 Univ California Terapia gênica para cardiomiopatia ventricular direita arritmogênica
WO2023159190A1 (en) * 2022-02-18 2023-08-24 Ginkgo Bioworks, Inc. Gene therapy for arrhythmogenic cardiomyopathy
IL315695A (en) * 2022-03-18 2024-11-01 Univ Florida Methods and compositions for treating RBM20-associated cardiomyopathy with a viral vector
EP4507713A4 (en) * 2022-04-11 2026-04-15 Tenaya Therapeutics Inc PLAKOPHILIN-2 BASED GENE THERAPY TREATMENT METHODS
US20260102513A1 (en) * 2022-09-21 2026-04-16 Rejuvenate Bio Gene therapy methods for arrhythmogenic cardiomyopathy
UY40442A (es) * 2022-09-22 2024-02-15 Biomarin Pharm Inc Tratamiento de la miocardiopatía arritmogénica con vectores de genoterapia con aav
CN116064612A (zh) * 2022-11-17 2023-05-05 百世诺(北京)医疗科技有限公司 肥厚型心肌病变异基因alpk3及其应用
CN122161621A (zh) * 2023-07-06 2026-06-05 加利福尼亚大学董事会 Alpk3心肌病的基因替代疗法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2792742A1 (en) * 2013-04-17 2014-10-22 Universitätsklinikum Hamburg-Eppendorf (UKE) Gene-therapy vectors for treating cardiomyopathy
WO2017083750A1 (en) * 2015-11-11 2017-05-18 Intrexon Corporation Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
WO2018208998A1 (en) * 2017-05-10 2018-11-15 The Regents Of The University Of California Directed editing of cellular rna via nuclear delivery of crispr/cas9
WO2019060619A1 (en) * 2017-09-20 2019-03-28 The Regents Of The University Of California STRATEGY OF GENE THERAPY FOR RESTORING ELECTRICAL AND CARDIAC FUNCTION AND CARDIAC STRUCTURE IN ARYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
DK3684423T5 (da) * 2017-09-20 2024-08-26 4D Molecular Therapeutics Inc Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf
CA3097375A1 (en) * 2018-04-27 2019-10-31 Universitat Heidelberg Modified aav capsid polypeptides for treatment of muscular diseases
CN109004092A (zh) 2018-06-29 2018-12-14 云谷(固安)科技有限公司 有机电致发光器件和有机电致发光装置
WO2022032226A1 (en) * 2020-08-07 2022-02-10 Spacecraft Seven, Llc Plakophilin-2 (pkp2) gene therapy using aav vector

Similar Documents

Publication Publication Date Title
JP2022508182A5 (cg-RX-API-DMAC7.html)
JP2024512483A5 (cg-RX-API-DMAC7.html)
JP2024056895A5 (cg-RX-API-DMAC7.html)
JP2022190081A5 (cg-RX-API-DMAC7.html)
JP2021512649A5 (cg-RX-API-DMAC7.html)
Grieger et al. Adeno-associated virus vectorology, manufacturing, and clinical applications
RU2018116076A (ru) Модифицированные гены атаксии фридрейха и векторы для генной терапии
JP2025162557A5 (cg-RX-API-DMAC7.html)
JP2022516004A5 (cg-RX-API-DMAC7.html)
JP2020528734A5 (cg-RX-API-DMAC7.html)
RU2017115477A (ru) Полинуклеотиды aadc для лечения болезни паркинсона
EP2660325A3 (en) AAV vectors and corresponding nucleotide sequences and methods
RU2017125234A (ru) Конструкции нуклеиновой кислоты и векторы для генотерапии для применения для лечения болезни вильсона и других состояний
JP2022551744A5 (cg-RX-API-DMAC7.html)
JP2017509632A5 (cg-RX-API-DMAC7.html)
JP2022524434A5 (cg-RX-API-DMAC7.html)
JP2020519284A5 (cg-RX-API-DMAC7.html)
JP2022525302A5 (cg-RX-API-DMAC7.html)
JP2019529385A5 (cg-RX-API-DMAC7.html)
JP2021523702A5 (cg-RX-API-DMAC7.html)
JP2022542828A5 (cg-RX-API-DMAC7.html)
JP2023537358A5 (cg-RX-API-DMAC7.html)
JP2017529395A5 (cg-RX-API-DMAC7.html)
IL292264B1 (en) Aav transfer cassette
JP2024517843A5 (cg-RX-API-DMAC7.html)